AMRN

#3363
Amarin Corp Plc
14.2000 USD
+1.72%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
14.2000
14.4200
Range Annuel
13.5100
17.0000
Changement quotidien
+1.72%
Changement Mensuel
-1.73%
Evolution sur 6 mois
-8.74%
Changement Annuel
-8.74%
Clôture Précédente
13.9600
Ouvrir
14.2500
Plus Bas
14.2000
High
14.4200
Volume
11
Afficher le graphique complet

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Amarin Corporation plc - American Depositary Shares, each repre

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza.

Nouvelles